🇺🇸 FDA
Patent

US 6995138

Cross-linked glycopeptide-cephalosporin antibiotics

expired A61KA61K38/00A61P

Quick answer

US patent 6995138 (Cross-linked glycopeptide-cephalosporin antibiotics) held by Theravance, Inc. expires Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Feb 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61P, A61P31/00, A61P31/04